Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Docetaxel + Xeloda + Avastin in Inflammatory or Locally Advanced Breast Cancer
NCT00576901Phase 2Terminated
- Sponsor
- Roche
- Start
- Nov 2007
- Primary completion
- Jun 2009
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of bevacizumab in breast cancer, sponsored by Roche. Started Nov 2007; status: terminated.
02
Drugs
bevacizumab
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00576901.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00576901.